Epix to cut work force, narrow research focus

10/23/2008 | AuntMinnie.com (free registration)

Epix Pharmaceuticals has announced plans to slash its work force by 23% and reduce its research and development focus in order to cut costs. The contrast-agent developer said it will concentrate on developing PRX-03140 for Alzheimer's disease and PRX-08066 for chronic obstructive pulmonary disease but will continue plans to market its Vasovist MRI contrast agent.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID